Tenax Therapeutics, Inc. · NASDAQ:TENX

Christopher Thomas Giordano reported a 4.32% stake in Tenax Therapeutics, Inc. (Schedule 13D/A)

Event Jul 31, 2026 · Filed Jul 31, 2026

Christopher Thomas Giordano reported a 4.32% stake in Tenax Therapeutics, Inc., 1,690,606 shares, with active intent on Jul 31, 2026. Filed Jul 31, 2026 (Schedule 13D/A).

Stake
4.32%
Shares
1,690,606
Intent
Active
What changed
Stake changed

The filing in full

HolderStakeShares
Christopher Thomas Giordano4.32%1,690,606

Source

View original at SEC

Related